Showing 37 - 41 of 41 results
Previous| 1... 2 | 3 | 4 |Next
Exclusive to Roswell Park, ‘Armored CAR’ Clinical Trial Targets CD19+ Hematologic Malignancies
Roswell Park Provides Support, Clinical Trials for Young Adult Sarcoma Patients
Next Generation Armored Car T-Cell Therapy Trial Now Open
FDA Expands Orphan Drug Designation for SurVaxM, Immunotherapy Developed at Roswell Park.
Clinical Trial Takes Aim at Promising Target in Advanced Gastric, Pancreatic Cancers
BROADCASTMED